Job Placement · Biotech and Life Sciences · Chief Scientific Officer
Biotech chief scientific officer placement on milestone billing, not contingency. The CSO owns scientific strategy, platform choices and external scientific credibility, priced near a 213,990 chief executive median, though the role often reaches the 316,850 to 507,730 range. BEG fills the seat in 23 to 35 days from 33,440.
See your exact placement price - no call required
See pricing before you talk to anyone. No demo gate, no obligation, and no co-employment.
TL;DR
A chief scientific officer owns the scientific strategy, the platform and pipeline choices, and the company's external scientific credibility, answering to the CEO and board. The closest BLS code, chief executives, prices the seat at a 213,990 median, though the functions a CSO consolidates reach the 316,850 to 507,730 range. BEG prices the search from 33,440.
Why This Search Stalls
The CEO and board often have not agreed whether they want a founder-type scientist who holds meaningful equity and sets the platform, or a senior operator who runs development for cash, so both candidate pools get interviewed and the modality-matched one leaves for a company that had decided.
How BEG Fills This Seat
BEG forces the founder-versus-operator decision before sourcing starts, scopes the seat to whole-organization strategy rather than execution, and prices candidates against chief executive and 90th-percentile bands instead of a manager-level median.
| Step | What it requires | Where it stalls |
|---|---|---|
| Force the founder-versus-operator decision | A board and CEO decision on whether the seat is a scientific founder-type with meaningful equity or a senior operator on cash and a modest grant | Boards interview both pools at once because they have not settled the question, and lose the modality-matched candidate to a company that had already decided |
| Scope the whole-organization mandate | A job description for scientific strategy, platform and pipeline choices, and external credibility with investors and partners, not just running R&D against a plan already set | Descriptions written like a VP of R&D role attract operators, not the strategy-setting scientist the board actually wants |
| Source against the CEO and 90th-percentile bands | Candidates priced anywhere from the 213,990 chief executive median to the 316,850 natural sciences manager 90th percentile | A budget anchored to the 167,220 all-manager median undershoots every realistic candidate for this seat |
| Close on the modality match | A finalist whose platform or pipeline experience matches CDER’s small-molecule and biologic pathway or CBER’s cell and gene therapy pathway | Indecision on equity structure loses the exact modality match to a competitor that moved first |
BLS says a Ph.D. is typically needed for independent biochemistry research and that natural sciences managers usually need five years or more as a scientist, so BEG screens CSO candidates for both the terminal degree and the operating track record.
Milestone Billing Against Contingency
BEG bills a fixed Tier VI milestone fee, 33,440 to 40,128, staged against the search rather than a percentage of the hire's salary, so the fee does not move with however the board ultimately structures cash against equity.
The Chief Scientific Officer Math
At the 213,990 median BLS reports for chief executives, the closest code to this seat, a 20 percent contingency fee runs 42,798 and a 25 percent fee runs 53,498 (BLS). BEG's Tier VI fee of 33,440 to 40,128 is 78 to 94 percent of that 20 percent figure, cheaper, though only by roughly 6 to 22 percent. At the 316,850 natural sciences manager 90th percentile, where the functions a CSO consolidates are actually priced, BEG runs 53 to 63 percent of a 20 percent fee, cheaper by 37 to 47 percent. Benchmarked instead against the 167,220 all-manager median, a figure too low for this seat, BEG's fee runs 100 to 120 percent of a 20 percent contingency fee, about the same as contingency or more expensive, not cheaper. Said plainly: BEG is cheaper at chief executive or 90th-percentile pay, the levels this seat is actually paid at, and only looks even or dearer against a manager-level median this role has outgrown.
Contingency, BEG, or Temp
Contingency fees on a founder-level total package run large; BEG's fixed Tier VI fee is cheaper at the pay levels a CSO actually commands, though not against a lower manager-level median.
| Model | Who employs | How you pay | Right when |
|---|---|---|---|
| Contingency recruiter | You, direct | A percentage of first-year salary, commonly 20 to 25 percent, due at start | A founder-level search where a fee tied to total compensation, equity included, is acceptable |
| BEG milestone placement | You, direct hire | A fixed Tier VI fee of 33,440 to 40,128, billed in stages against the search | A CSO hire priced at chief executive or 90th-percentile manager pay, where BEG runs well below a 20 percent contingency fee |
| Staffing or temp agency | The agency, not you | An hourly bill rate with markup, for as long as the assignment runs | Interim scientific leadership during a transition, not a permanent CSO hire |
See every tier and role BEG places across the vertical on the hub.
FAQ
The CSO owns the scientific strategy, the platform and pipeline choices, external scientific credibility with investors and partners, and the research organization as a whole, answering to the CEO and board. A VP of R&D, who runs development against a strategy already set, does not own that whole-company mandate.
The CEO and board often have not agreed whether they are hiring a founder-type scientist who will hold meaningful equity and define the platform, or a senior operator who will run development for cash and a modest grant. Candidates from both pools get interviewed, the structure cannot be settled, and the modality match is lost to a company that had already decided.
The closest BLS code, chief executives, prices the seat at a 213,990 median with a 507,730 90th percentile. The scientific and management functions a CSO consolidates are also priced at the natural sciences manager 90th percentile of 316,850.
Yes at the pay levels this seat is actually paid, chief executive median or 90th-percentile manager pay, where BEG runs 6 to 47 percent cheaper depending on benchmark. Against a lower all-manager median, a figure too low for this seat, BEG runs about the same as contingency or slightly more, not cheaper, and this page says so plainly.
BEG bills a fixed Tier VI milestone fee of 33,440 to 40,128 for this role, staged against the search and unaffected by how the board ultimately splits cash and equity.
No. BEG places chief scientific officers as your direct, permanent employees on milestone billing, not as interim executives.
BEG averages 23 to 35 days to fill an active CSO search, with an 86 percent fill rate on searches it runs.
BLS says a Ph.D. is generally required for independent biochemistry research, and that natural sciences managers typically need five years or more as a scientist, with some employers requiring a Ph.D. A CSO candidate usually combines both the terminal degree and a management track record.
An unresolved decision on the equity-versus-cash structure of the offer. When the board has not settled whether the hire is a founder-type or an operator, the candidate whose modality experience actually matches the lead program accepts an offer elsewhere.
FDA’s September 2025 E6(R3) Good Clinical Practice guidance and Current Good Manufacturing Practice rules, under which a drug made outside CGMP is legally adulterated regardless of whether the product itself has a defect.
Most biochemistry Ph.D. holders begin in temporary postdoctoral positions, which NIH funds at a 63,480 stipend in year 0, capped at 3 years of support, the pipeline a CSO draws junior scientific talent from.
A VP runs the research organization against a strategy already set by the CSO and answers to the CSO or CEO. The CSO sets that strategy, owns the platform and pipeline choices, and carries external scientific credibility with investors, one level above the VP.
Compare this seat with the VP of R&D / clinical role below it, or the Ph.D.-level scientist seat the CSO’s bench is built from. Every biotech role BEG places is on the Biotech and Life Sciences hub.
More Biotech and Life Sciences placement
Ready?
Answer a few questions, get your exact number in about 90 seconds. No call required, no commitment.
See your exact placement price - no call required
